19 results
Thumbnail

D3.339 - Severe β-lactam hypersensitivity phenotypes in routine care: anaphylaxis frequency in a 22-centre outpatient survey in China

Thumbnail

D3.340 - The importance of de-labeling contrast allergy în cardiology department - clinical case

Thumbnail

D3.341 - Alignment with International Anaphylaxis Management Guidelines in a Tertiary Referral Center in Central Asia: A Retrospective Clinical Audit

Thumbnail

D3.342 - Adverse Events of Biologic Therapies: A One-Year Retrospective Study

Thumbnail

D3.343 - Hereditary alpha-tryptasemia: clinical variability and anaphylaxis triggers in six genetically confirmed cases

Thumbnail

D3.344 - Rapid Desensitization to Iohexol Following Iopamidol-Induced Anaphylaxis Prior to Urgent Coronary Angiography

Thumbnail

D3.345 - Anaphylactic Shock: Clinical Analysis of 8 Cases with Post-Hospital Outpatient Follow-Up

Thumbnail

D3.346 - From Anaphylaxis to Oral Allergy Syndrome: Multiple Seed Hypersensitivity in a Single Pediatric Patient

Thumbnail

D3.347 - Idiopathic Anaphylaxis: A Diagnostic Challenge

Thumbnail

D3.348 - Alpha‑gal Syndrome in Young People: A Call for Public Health Awareness in Tick‑Endemic Areas of Scotland and North East England

Thumbnail

D3.349 - Takotsubo cardiomyopathy triggered by anaphylaxis after a honey bee sting, forming ATAK complex: a rare case report

Thumbnail

D3.351 - A case of Kounis syndrome in idiopathic anaphylaxis and indolent systemic mastocytosis

Thumbnail

D3.352 - Long-term analytical stability of ImmunoCAP tryptase supports enduring clinical interpretation thresholds

Thumbnail

D3.353 - Clinical Characteristics and Triggers of Pediatric Anaphylaxis Cases: A Retrospective Single-Center Experience

Thumbnail

- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells

Thumbnail

- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study

Thumbnail

- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib

Thumbnail

- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series

Thumbnail

- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis